Nevada Watch
Featured news in this section focuses on Nevada, the Silver State Health Insurance Exchange (Nevada Health Link), the Nevada Division of Insurance (in the Department of Business and Industry), and actions by the state legislature affecting insurance brokers and clients.
The dozen ObamaCare exchanges run by the states are struggling financially and could be headed toward collapse over the next several years, according to a new report released Tuesday by House Republicans.
Early in August commercial health insurer Humana Inc. disclosed it was joining a growing list of big insurance companies scaling back participation in public health exchanges.
If premiums for Nevadans covered by the Affordable Care Act increase substantially next year, most will still be able to get coverage for $100 a month or less because of a built-in buffer against insurance rate hikes written into the law, federal health officials said Wednesday.
Patients who gained health coverage through the Affordable Care Act are filling significantly more prescriptions while paying less for their drugs, according to a new study that credits the health law and adds to evidence of its benefits for previously uninsured Americans and those with chronic conditions such as asthma, diabetes and high blood pressure.
Five Southern Nevada hospitals were among six statewide that received only one star in a controversial five-star rating system unveiled Wednesday by the Centers for Medicare & Medicaid Services.
The Nevada Division of Insurance is pleased to announce the launch of its “Proposed Rates” digital campaign encouraging Nevadans to review and comment on the proposed health insurance rates for 2017.
Health insurance costs for about 240,000 Nevadans who buy individual or small-group plans are expected to rise next year, and state officials want consumers to offer feedback before the proposed rates are locked in in coming weeks.
A new study takes a fresh measure of generic drugs’ price advantages, revealing how much more Medicare Part D patients shelled out in copayments for two popular brand-name drugs in 2013.
The Obama administration knowingly spent billions in health care dollars without proper congressional authority and went to “great lengths” to impede congressional scrutiny of the money, Republicans on two major House committees said in a report that will be made public on Thursday.
Obamacare prices are all over the map.